Navigation Links
Sirion Therapeutics Announces Clinical Data Presentations at the 2009 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Date:4/30/2009

TAMPA, Fla., April 30 /PRNewswire/ -- Sirion Therapeutics, Inc. announced today that eight presentations related to the Company's products, pipeline and research will be presented at the 2009 annual meeting of The Association for Research in Vision and Ophthalmology (ARVO) in Ft. Lauderdale, FL.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080220/CLW064LOGO)

These presentations include data related to Durezol(TM) (difluprednate ophthalmic emulsion) 0.05%, fenretinide, and retinal research programs from the Sirion San Diego, CA based drug discovery laboratory.

Durezol (difluprednate ophthalmic emulsion) 0.05% was approved by the U.S. Food & Drug Administration (FDA) after an expedited review in June 2008 for the treatment of post-operative inflammation and pain associated with ocular surgery. A supplemental New Drug Application (sNDA) was filed in December 2008 seeking an approval for Durezol as a treatment for endogenous anterior uveitis based partially on a head to head comparison to Pred Forte(R). The application was accepted in February 2009 by the agency and is under review.

Fenretinide is currently being evaluated in an ongoing phase II clinical trial in the treatment of geographic atrophy (GA) associated with age-related macular degeneration (AMD). The trial is a two year multicenter, randomized, double-masked, placebo controlled, dose-comparison in over 225 patients at 30 sites in the United States. A summary of the preliminary results of a planned interim analysis of this study was provided in a press release made by Sirion on April 15th, 2009. The ARVO presentations on fenretinide contain a more detailed analysis of the data obtained from the interim analysis.

Identified below are the presen
'/>"/>

SOURCE Sirion Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Sirion Therapeutics Announces Positive Phase III Results for Difluprednate
2. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
3. Sirion Therapeutics Announces Positive Pivotal Uveitis Data for Durezol(TM)
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
10. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
11. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013  Millennium HealthCare Inc. (OTC ... into an exclusive 25-year Supply and Distribution agreement ... Corporation ("EWC") for its Distance Monitored Physical Therapy ... physical therapy program is a critical element in ... said Chris Amandola , president, Millennium HealthCare ...
(Date:6/18/2013)... , June 18, 2013  Specialty ... significant breakthrough in Parylene coating technologies: SCS ... the benefits of Parylene with antimicrobial properties ... devices and components. (Logo: ... infections (HAIs) increase and continue to pose ...
(Date:6/18/2013)... MPR is excited to unveil a new logo and ... of an ongoing effort to freshen the look and feel ... years. (Photo: http://photos.prnewswire.com/prnh/20130618/NY33937 ) ... has expanded upon its foundation as a concise drug information ... array of clinical and practice management tools including a cloud-based ...
Breaking Medicine Technology:Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 2Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 3Specialty Coating Systems Announces New Antimicrobial Parylene Technology 2MPR Sports a Bold New Look 2
... The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine ... as its July 2010 "Stock to Study" and Gilead ... for investors, informational and educational use. , ... "The committee chose Teva Pharmaceutical Industries because of the tremendous ...
... EAST BRUNSWICK, N.J. , April 30 Savient Pharmaceuticals, Inc. (Nasdaq: ... the first quarter 2010 following the close of the market on Wednesday ... , ... Financial Officer, will host an investment community conference call beginning at 10:00 ...
Cached Medicine Technology:BetterInvesting Magazine Releases July's Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 2BetterInvesting Magazine Releases July's Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 3Savient Pharmaceuticals To Hold First Quarter 2010 Results 2
(Date:6/18/2013)... June 18, 2013 Today, Zane Benefits, ... Reimbursement Accounts . Zane Benefits, which provides comprehensive and ... the leader in defined contribution and ... Benefits’ website, employees of a company who sets up ... questions about how Health Reimbursement Accounts work. Educating employees ...
(Date:6/18/2013)... New York, NY (PRWEB) June 18, 2013 ... Sinai Medical Center to its “Best Doctors” list, up ... in New York City. The new issue also lists 52 ... network, which continues on a strategic growth trajectory. The “Best ... physicians, appears in the June 24 print issue and is ...
(Date:6/18/2013)... Local chemical signals released by fat cells in the ... exposure to unrelenting social stressors early in life, and ... University of Chicago report in the July 2013 issue ... Some forms of stress exposure may be associated with ... cancer. But the mechanisms linking the biology of social ...
(Date:6/18/2013)... June as Lesbian, Gay, Bisexual and Transgender ... civil rights, sexual minority youth are still ... heterosexual peers, according to the Suicide Prevention ... graduate student recently published recommendation to improve ... could help improve psychological functioning and reduce ...
(Date:6/18/2013)... 2013)-- An international team of investigators co-led by Weill ... evidence-based surgery and device research, similar to the kind ... , "Currently, there is no dynamic research framework to ... benefits to patients or may even be harmful," says ... College. , In the June 18 issue of ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on Health Reimbursement Accounts 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 4Health News:Sexual minority youth need specialized treatment from therapists 2Health News:Tackling a framework for surgical innovation 2Health News:Tackling a framework for surgical innovation 3
... published in the Journal of Vascular Surgery reported that ... better// when accompanied by a suction device to remove ... kidneys. ,Researchers from the Wake Forest University ... that short, less invasive procedures restored enough blood flow ...
... now investigating Dr Wakefield over claims of serious professional misconduct//. ... Wakefield and subsequently published in The Lancet in 1998, had ... might exist a causal link between the combined measles, mumps ... ,Reports now indicate that the GMC is now charging ...
... The death of a 65-year-old woman at the ... Ms Hannah Comber died //from asphyxiation after she ... special chair.,The HSE said, it is fully co-operating ... into the incident at a continuing care facility ...
... have found that astemizole, which is used for treating ... for treating malaria//. ,According to a study conducted ... Public Health and the Johns Hopkins University School of ... Malaria Research Institute (MRI), determined that in a test ...
... the urology segment, pharma major Dr Reddys Laboratories Ltd ... release tablets of 10 mg dosage. ... indicated for treatment of enlargement of prostate gland in ... company release said., ,The product was launched nationwide, ...
... volunteers have found that external ‘condom’ catheter showed lesser ... ,An 80 per cent reduction in urinary ... was collected with condom type catheter, which proved a ... ,In fact, men whose urine was collected with an ...
Cached Medicine News:Health News:Blood Flow to Kidneys Better Restored by Less Invasive Procedures 2Health News:Antihistamine Could also be used as a Potential Antimalarial Drug 2Health News:External Catheters Linked with decreased UTI Risk in Men 2Health News:External Catheters Linked with decreased UTI Risk in Men 3Health News:External Catheters Linked with decreased UTI Risk in Men 4
... the quantitative determination of Erythropoietin (EPO) in human ... diagnostic use, as an aid in the diagnosis ... the administration of recombinant erythropoietin as a biologic ... erythropoietin assay may be used also to aid ...
... The innovative PoleStar N20, exclusively ... for intra-operative MRI. Combining intra-operative ... completely registration-free system, PoleStar N20 is ... tools available today. , , Exceptional ...
... PREMIUM SURGICLIP II™ single use ... Super Interlock™ clips., ,The ... applier has application in many ... occlude vessels and other tubular ...
... Powered LDS™ single use stapler places two ... cartridge jaw and a knife which divides ... , ,The Auto Suture™ Powered LDS™ ... application in abdominal, gynecological, orthopedic, and thoracic ...
Medicine Products: